|
The Immunohistochemistry Antibody Company
|
|
|
Laryngeal Cancer Screen 7 Tissue Microarray - LS-SLXCA7This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SLXCA7 |
| Product Name: | Laryngeal Cancer Screen 7 |
| Description: | Larynx and pharynx cancer with stage/grade and unmatched normal/non-neoplastic specimens |
| Format: | FFPE |
| Category: | Human Tumor and Normal |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 48 |
| Cores: | 48 |
| Slides Per Set: | 1 |
LS-SLXCA7 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Laryngeal proper gland (Gln); Larynx (Lrx); Larynx, Fibrous tissue, blood vessel, and skeletal muscle (Lrx); Larynx, Vocal cord (Lrx); Pharynx (Pyx);
LS-SLXCA7 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Grade |
|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 42 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T3N1M0 | 1 |
| 1 | A2 | Human | M | 54 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 |
| 1 | A3 | Human | M | 67 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 1 |
| 1 | A4 | Human | M | 63 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 1 |
| 1 | A5 | Human | M | 69 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N1M0 | |
| 1 | A6 | Human | M | 66 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 1 |
| 1 | A7 | Human | M | 60 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 |
| 1 | A8 | Human | M | 43 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 1 |
| 1 | B1 | Human | F | 39 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T3N0M0 | 1 |
| 1 | B2 | Human | M | 60 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4NxM0 | 1 |
| 1 | B3 | Human | M | 52 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | 1 | |
| 1 | B4 | Human | F | 44 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T1aN0M0 | 1 |
| 1 | B5 | Human | M | 51 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 1 |
| 1 | B6 | Human | M | 44 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T1aN0M0 | 1 |
| 1 | B7 | Human | M | 72 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 |
| 1 | B8 | Human | M | 56 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4NxM0 | 1 |
| 1 | C1 | Human | M | 60 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T3N0M0 | 1 |
| 1 | C2 | Human | M | 57 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N1M0 | 1 |
| 1 | C3 | Human | M | 52 y | Larynx, Fibrous tissue, blood vessel, and skeletal muscle (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | |
| 1 | C4 | Human | M | 50 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | 2 | |
| 1 | C5 | Human | M | 72 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 2 |
| 1 | C6 | Human | M | 62 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 2 |
| 1 | C7 | Human | M | 55 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 |
| 1 | C8 | Human | M | 55 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 |
| 1 | D1 | Human | M | 55 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 |
| 1 | D2 | Human | M | 56 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T3N0M0 | 2 |
| 1 | D3 | Human | M | 57 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N1M0 | 2 |
| 1 | D4 | Human | M | 50 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T3N0M0 | 2 |
| 1 | D5 | Human | M | 51 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | D6 | Human | F | 54 y | Laryngeal proper gland (Gln) | Squamous cell carcinoma with chronic inflammation | Malignant | T2N0M0 | |
| 1 | D7 | Human | M | 59 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4NxM0 | 2 |
| 1 | D8 | Human | M | 50 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N3M1 | 2 |
| 1 | E1 | Human | M | 50 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T3N1M0 | 2 |
| 1 | E2 | Human | F | 52 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N1M0 | 2 |
| 1 | E3 | Human | M | 61 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N1M0 | 2 |
| 1 | E4 | Human | F | 57 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T1N0M0 | 3 |
| 1 | E5 | Human | M | 58 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4N0M0 | 3 |
| 1 | E6 | Human | M | 41 y | Pharynx (Pyx) | Squamous cell carcinoma | Malignant | 3 | |
| 1 | E7 | Human | F | 52 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N1M0 | |
| 1 | E8 | Human | M | 46 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T4NxM0 | 3 |
| 1 | F1 | Human | F | 42 y | Larynx (Lrx) | Normal | Benign non-neoplastic | ||
| 1 | F2 | Human | M | 43 y | Pharynx (Pyx) | Normal | Benign non-neoplastic | ||
| 1 | F3 | Human | M | 45 y | Larynx (Lrx) | Normal | Benign non-neoplastic | ||
| 1 | F4 | Human | F | 15 y | Larynx (Lrx) | Normal | Benign non-neoplastic | ||
| 1 | F5 | Human | M | 16 y | Larynx, Vocal cord (Lrx) | Normal | Benign non-neoplastic | ||
| 1 | F6 | Human | M | 43 y | Pharynx (Pyx) | Normal | Benign non-neoplastic | ||
| 1 | F7 | Human | F | 21 y | Larynx (Lrx) | Normal | Benign non-neoplastic | ||
| 1 | F8 | Human | M | 48 y | Larynx, Vocal cord (Lrx) | Normal | Benign non-neoplastic |